We are pleased to announce that the enrollment for International Multicenter Phase II study in patients with Non-Hodgkin lymphoma was successfully completed in September. Due to the efficient work of Ukrainian sites, which were included in the study this summer, the required number of participants was randomized within very short period.

This study is of a high importance for GCT, and our team looks forward to its successful and smooth close-out.

Pictured: Aerial panorama of Kiev.